Imagine a world where those living with Type 1 Diabetes, a chronic illness affecting more than 60 million adults globally, no longer had to deal with regular blood glucose monitoring, daily insulin injections or life-threatening nighttime hypoglycemic events, but instead could eat, exercise and sleep worry-free. Thats the kind of future an up-and-coming breakthrough technology is on track to creating.
Beta-O2 Technologies, a privately held biomedical company headquartered in Israel with research and industry affiliates across the U.S., is working to deliver a first-of-its-kind bio-artificial pancreas as a safe, effective and long-term cure for the disease. With preliminary animal trials showing promising results for its second generation breakthrough device, called Bio-artificial Pancreas (Air), the company is planning to begin human clinical trials within the year.
We have strong pre-clinical evidence to prove the safe operation of our device on animals, said Beta-O2 CEO Amir Lichter, noting that the second generation Air is performing well in ongoing animal studies. Its an enormous achievement that is paving the road for human trials.
Measuring approximately 2.5 by 2.5 inches, Air is made of titanium. It has two components: a macrocapsule that contains pancreatic cells and an oxygen tank equipped with an external port, so patients can easily refresh oxygen levels weekly. Once implanted under a patients skin, it becomes a natural source of insulin, sensing blood glucose levels and delivering insulin as required.
While there are a couple of other artificial pancreatic solutions being explored by different industry players, Beta-O2s disruptive technology is the only bio-artificial pancreas to incorporate an active oxygen supply, necessary to keep the pancreas cells in the implanted device functional and viable over the long term. Other solutions are demonstrating limited success because they rely on a patients bloodstream to deliver enough oxygen to keep the transplanted cells viable, which is problematic, Lichter explained.
Pancreas cells (islets) are extremely delicate, he said. We solve the problem by proactively supplying oxygen through an external source, providing a superior solution.
Lichter said the beauty of the Beta-O2 solution which holds 10 global patents for its exclusive immune protection capabilities and oxygen supply mechanisms is that its very generic, meaning it can contain cells from a human donor, cells from the pancreas of a pig, or cells derived in a lab from stem cells. Other advantages are that Beta-O2s bio-artificial pancreas does not require a patient to take intensive immunosuppression therapies after implant due to its protective encapsulation capabilities, and the device can quickly be retrieved from a patient if necessary due to malfunction or other health concerns, he explained.
Beta-O2 is currently collaborating with several U.S.-based pharmaceutical companies and academics, including researchers from Harvard University, MIT, University of Virginia and Cornell University, to further enhance the Air oxygen supply and its ability to measure glucose levels and secrete insulin once implanted. The company is also in negotiations to solidify its collaboration with several stem cell providers as it looks to secure an additional $15 million in investment funds to support its aggressive go-to-market strategy.
The active oxygen supply used by Beta-O2 is currently the best and most advanced technique for maintaining viability and function of large numbers of pancreaticislets (or stem cell-derived islets) in an encapsulation transplantation device, said Clark K. Colton ofthe Department of Chemical Engineering at MIT andBeta-O2 Scientific Advisory Board member.
Calling the Beta-O2 device a next-gen treatment option, Dr. Jos Oberholzer, Professor of Surgery, Biomedical Engineering and Experimental Pathology at the University of Virginia and Beta-O2 Scientific Advisory Board member, explained that after years of insulin injections and closed-loop insulin pumps and glucose sensors, patients will finally have access to a biological device solution to treat the most brittle forms of diabetes. The Beta-O2 device is the only implant that has shown reproducible results in humans with diabetes, with measurable insulin production originating from human islet cells within the device without the need for recipients to take any immunosuppressive drugs.
An earlier safety trial involving four patients in Sweden, supported by New York-based JDRF (Juvenile Diabetes Research Foundation), successfully demonstrated that Beta-O2s device is fully safe for use. No side effects were observed in patients who carried the device for up to 10 months, and the cells remained viable and functional.
Now, current animal trials underway at Beta-O2 are focused on extending the life of functional cells even further, with promising early results showing that rats implanted with Air are maintaining normal glucose levels.
With tangible evidence that we can maintain the viability and functionality of our cells for a long duration in rats, which have an immune system very similar to humans, we are looking forward to moving ahead with our second round of human clinical trials, Lichter said, noting that the company aims to be first to show that implanted biological pancreatic cells can successfully achieve normal blood sugar levels in diabetic patients without the need for immunosuppression therapy.
___________________________________________________________
About Beta-O2 Technologies Ltd. (www.beta-o2.com)
Beta-O2 Technologies Ltd. is a biomedical company developing a proprietary implantable bioreactor, the Air, for the treatment of Type 1 Diabetes. Air is designed to address the main problems of the otherwise successful procedures in which islets of Langerhans (i.e. pancreatic endocrine cells) are transplanted in diabetic patients, such as the need for life-long immunosuppressive pharmacological treatment and limited functionality of the transplanted islets over time due to an insufficient oxygen supply. Beta-O2 investors include SCP Vitalife Partners, Sherpa Ventures, Aurum Ventures, Pitango Venture Capital, Saints Capital, Japanese and Chinese private investors.
See original here:
First-of-its-Kind Bio-Artificial Pancreas on Track for Type-I Diabetes Cure - Global Trade Magazine
- Long COVID-19 May Stem From an Overactive Immune Response in the Lungs - SciTechDaily - October 13th, 2022
- Long COVID-19 and other chronic respiratory conditions after viral infections may stem from an overactive immune response in the lungs - Huron Daily... - August 5th, 2022
- DiPersio receives awards recognizing contributions to cancer care, research Washington University School of Medicine in St. Louis - Washington... - July 27th, 2022
- With Supreme Court Failing California, Is It Time to Go on Our Own? - zocalopublicsquare.org - July 11th, 2022
- PARP Inhibitors Are Under Study as Treatment Options Beyond BRCA-Mutated Breast Cancer - OncLive - May 15th, 2022
- What it's like to compete in the science fair 'Olympics' - Science News for Students - May 15th, 2022
- Plug-and-play organ-on-a-chip can be customized to the patient - EurekAlert - May 2nd, 2022
- 'Where Does It Hurt?': Primary Care Tips for Common Ortho Problems - Medscape - May 2nd, 2022
- Pollution could be sucking the youth out of you, quite literally - ZME Science - June 23rd, 2021
- Habitable Earth an anomaly? Awardees of STEM grants study this and more | University of Hawaii System News - UH System Current News - June 6th, 2021
- Clint Smith's 'How The Word Is Passed' And Race History - NPR - June 6th, 2021
- Study: Israeli-made anti-COVID nasal spray reduced infection at mass gathering - The Times of Israel - February 23rd, 2021
- Novel Bone Marrow 'Ingredient' To Help Arthritic Horses The Horse - TheHorse.com - February 7th, 2021
- Anatomy of a vaccine: What it takes to create a safe, effective COVID shot - University of California - December 9th, 2020
- U.S. elections bring wins and losses for research community - Science Magazine - November 5th, 2020
- Viewpoint: Rightwing packing on Supreme Court means ERA more crucial than ever to protect Women's Rights - Blog - The Island Now - November 5th, 2020
- Talaris Therapeutics Announces Collaboration With Kentucky Organ Donor Affiliates to Advance Preclinical Study of Tolerance Induction to Organs From... - September 18th, 2020
- Alleged unwanted hysterectomies and other abuses at ICE facility prompts investigation - USA TODAY - September 18th, 2020
- WVU assistant professor receives $3 million to study impacts of air pollution on lungs - The Daily Athenaeum - thedaonline - August 31st, 2020
- Landmark transplant in 1960s Virginia performed with heart stolen from a Black man - Live Science - August 12th, 2020
- Surrozen reloads with $50M for final dash to the clinic, shines some light on lead Wnt-modulating candidates - Endpoints News - June 20th, 2020
- Focused Ultrasound Opening Brain to Previously Impossible Treatments - University of Virginia - May 12th, 2020
- Bent into shape: The rules of tree form - Knowable Magazine - February 4th, 2020
- Q&A: Cancer Death Rates Are Falling Nationally. Here's What's Happening at UVA - University of Virginia - January 11th, 2020
- Brown fat warms your body in cold weather | NOVA - NOVA Next - December 30th, 2019
- Oliver and Elizabeth Hedgepeth column: Human donations are a gift of life - Richmond.com - November 25th, 2019
- Dr. Christopher Good | Spinal Surgeon | Virginia Spine - May 13th, 2019
- Top 25 Most Haunted Places in Virginia - Colonial Ghosts - May 13th, 2019
- Stem Cell Therapy in Dallas, TX | National Stem Cell Centers - March 5th, 2019
- Stem Cell Injections Richmond, Virginia | Alternative to ... - February 24th, 2019
- Virginia Beach VA 23460 - National Stem Cell Therapy - February 22nd, 2019
- Stem Cell Richmond Virginia 23230 - January 5th, 2019
- Stem Cell Transplantation at Virginia Oncology Associates - November 23rd, 2018
- Stem Cells Lynchburg VA | Stem Cell Recovery SW Virginia - July 24th, 2018
- Stem Cell Therapy - Virginia Spine Institute - July 11th, 2018
- PRP & Stem Cell Treatment in Richmond VA - Dr. Bill Nordt ... - July 11th, 2018
- Stem Cell Therapy Hair Growth | McLean | Virginia Surgical ... - October 15th, 2017
- SpaceX Dragon Delivers Supplies (and Science) to Space Station - Space.com - August 19th, 2017
- John Theurer Cancer Center and MedStar Georgetown University Hospital Announce 100 - Business Wire (press release) - August 5th, 2017
- Grant supports 3D innovation in stem cell-related cancer research at ODU - Southside Daily - August 5th, 2017
- Roanoke researchers pursue treatments for the type of deadly brain cancer affecting McCain - Richmond.com - August 5th, 2017
- Everything's a hustle in Orphan Black episode 5.5 - SYFY WIRE (blog) - July 9th, 2017
- Tests show no signs of cancer for Danville 2-year-old - GoDanRiver.com - July 6th, 2017
- U.Va. Smashes Barrier to Growing Organs from Stem Cells ... - November 23rd, 2016
- Stem Cell Therapy for Neck & Back Pain - DC Metro Area - November 23rd, 2016
- Home - StemCell ARTS - October 30th, 2016
- Stem Cell Transplantation - Virginia Cancer - October 30th, 2016
- Regenerative Medicine Research - Virginia-Maryland College ... - October 30th, 2016
- NASA awards UCI $9 million to study underlying mechanisms of 'space brain' - March 18th, 2015
- New ACL Preservation at G2 Orthopedics and Sports Medicine - February 20th, 2015
- Most cancers are just bad luck, others from bad genes, environment - January 20th, 2015
- The Week That Was: Bear Down - December 22nd, 2014
- Stem cells and cell adaptations to particular functions - December 19th, 2014
- Billionaire's New Science Institute Plans 'Google Maps' View Of Cells - December 9th, 2014
- Ridiculously tiny stomachs created for disease experiments - October 30th, 2014
- Misfolded Proteins Clump Together in a Surprising Place - October 16th, 2014
- Why Didn't They Win? 10 Huge Discoveries Without a Nobel Prize - October 9th, 2014
- Cell Stem Cell Protocol Review - Medicine School of ... - September 27th, 2014
- Stem Cells Symptoms, Causes, Treatment - Fetal stem cells ... - September 27th, 2014
- Williamsburg Stem Cell Therapy, Stem Cell Therapy ... - September 25th, 2014
- Virginia Beach Stem Cell Therapy, Stem Cell Therapy ... - September 25th, 2014
- Posts Tagged virginia - virginia StemCell Doctors - August 29th, 2014
- Virginia (Stem Cell) - what-when-how - August 22nd, 2014
- About Us - StemCell ARTS - Stem Cell Therapy and PRP for ... - August 22nd, 2014
- Virginia Stem Cell Treatments | Stem Cell Treatments - August 22nd, 2014
- Stem Cell Therapy Virginia | Stem Cell Treatments - August 22nd, 2014